source
- Vitruvias Therapeutics recalls one lot of 30 mg thyroid tablets over super potency riskVitruvias Therapeutics announced a voluntary recall of a single lot (Lot No. 504950) of its 30 mg thyroid tablets to the consumer level. Testing confirmed the tablets could be superpotent, raising…
- FDA issues early alert on CooperSurgical infant nasal CPAP devices with loose tubing connectionThe FDA’s Center for Devices and Radiological Health has posted an Early Alert about a potential high-risk issue with certain CooperSurgical infant nasal CPAP devices. The problem involves a loose…fda medwatch · 19d agoRegulatoryNegative